LC-MS Innovations Facilitate Pioneering Testing Capabilities in Forensic and Clinical Toxicology

Significance of the Topic

The use of non-invasive biological samples such as oral fluid and capillary blood for drugs of abuse testing addresses limitations of traditional urine analysis, including sample adulteration and patient discomfort. Rapid, sensitive and reliable screening methods are essential for forensic and clinical applications, enabling accurate detection of a wide range of substances at trace levels.

Objectives and Study Overview

This case study describes how MVZ Medizinische Labore Dessau Kassel GmbH, in collaboration with Waters Corporation, developed pioneering LC-MS/MS methods to improve throughput and sensitivity for drug monitoring. Key goals included replacing immunoassay screening, expanding multi-target analysis, and validating workflows for oral fluid and capillary blood in forensic and clinical toxicology.

Methodology and Instrumentation Used

MVZ implemented advanced liquid chromatography–tandem mass spectrometry using:

• Waters ACQUITY UPLC I-Class System
• Waters Xevo TQ-XS Tandem Quadrupole Mass Spectrometer
• Waters MassLynx Mass Spectrometry Software
• Waters UniSpray Ion Source (USI) with post-column HCl infusion

This configuration enabled broad analyte coverage, high dynamic range and improved desolvation for enhanced ionization. Sample preparation was streamlined for oral fluid swabs and 20 µL capillary blood spots, reducing solvent use and preparation time.

Key Results and Discussion

• Multi-target screening detected up to 73 substances in oral fluid and 81 in capillary blood, including opioids, benzodiazepines, synthetic cannabinoids and fentanyl analogues.
• Low limits of quantification (0.1–1.0 ng/mL) facilitated detection of trace compounds and their metabolites.
• LC-MS/MS workflows eliminated presumptive immunoassays, reducing false positives and negatives while providing quantitative data directly.
• Non-invasive sampling reduced fraud risk and improved patient compliance compared to supervised urine collection.
• High throughput was achieved with faster run times, consolidated methods and minimal source switching.

Benefits and Practical Applications

The developed methods offer:

• Enhanced forensic validity with ISO-accredited confirmatory data for legal cases.
• Clinical monitoring of therapeutic and illicit drug use in addiction medicine, psychiatric settings and correctional facilities.
• Cost and time savings by reducing sample prep, consumables and analysis steps.
• Environmental benefits through decreased solvent consumption and smaller sample volumes.

Future Trends and Potential Applications

MVZ anticipates further advances in:

• Software integration with machine learning for automated result pairing, interpretation and reporting.
• Intuitive user interfaces to streamline workflows and support regulatory compliance.
• Expanded analyte libraries and specialized LC-MS technologies to detect emerging psychoactive substances.
• Continued collaboration with instrument vendors to optimize sensitivity and throughput for novel sample types.

Conclusion

The collaboration between MVZ and Waters has resulted in state-of-the-art LC-MS/MS methods for non-invasive drug testing in forensic and clinical toxicology. These innovations deliver high sensitivity, robust multi-target screening and efficient workflows, positioning MVZ as a leader in next-generation toxicology services.

References

• Neumann J, Keller T, Monticelli F, Beck O, Böttcher M. Ethyl glucuronide and ethanol concentrations in femoral blood, urine and vitreous humor from 117 autopsy cases. Forensic Science International. 2021;318:110567.
• Böttcher M, Kühne D, Beck O. Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse®) using oral fluid as specimen. Clinical Mass Spectrometry. 2019;14(Pt B):99–105.
• Böttcher M, Lierheimer S, Peschel A, Beck O. Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing. Drug and Alcohol Dependence. 2019;198:136–139.